Evidence map›Paper›PMID 40641785›Full record

ArticleJTCVS techniques2025

Resection and reconstruction of the left atrium with cardiopulmonary bypass for T4 non-small cell lung cancer.

Lin Zhou, Zhipeng Hao, Kun Huang, Yuchen Chen, Ni Zhang, Xiangning Fu, Yangkai Li

Abstract read
In one paragraph

Article in JTCVS techniques, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lin ZhouDepartment of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhipeng HaoDepartment of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Kun HuangTongji School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yuchen ChenTongji School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Ni ZhangDepartment of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xiangning FuDepartment of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yangkai LiDepartment of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Radical surgery for T4 non-small cell lung cancer, especially for those tumors invading the heart, poses a significant challenge for thoracic surgeons, as demonstrated by the paucity of previous reports. This study aimed to report our surgical technique and experience with this radical surgery that necessitated cardiopulmonary bypass and to assess the prognosis of these patients with locally advanced non-small cell lung cancer. Methods: This study included 4 patients with non-small cell lung cancer (enrolled between 2010 and 2020) who underwent en bloc tumor resection and reconstruction of the left atrium with cardiopulmonary bypass. The clinical features, preoperative assessment, surgical technique, and outcomes of these patients were reviewed. Results: All patients received complete R0 resection and reconstruction. The mean operative and cardiopulmonary bypass times were 370.5 ± 100.7 minutes and 20.3 ± 13.8 minutes, respectively. One patient died within 30 days after surgery, 2 patients died 46 days and 7 months postoperatively, and 1 patient is still alive 47 months postoperatively without recurrence or metastasis. Conclusions: In the contemporary era of targeted and immunotherapy, surgical intervention may offer a viable alternative for patients with T4 NSCLC involving the left atrium who have exhibited resistance to neoadjuvant therapeutic regimens.

Indexed as

cardiopulmonary bypassheartlung cancerlung resectionreconstruction

Identifiers

PMID40641785
PMCPMC12237782

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.